EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Innovent Biologics Surges After Signing Up to $10.5 Billion Deal With Pfizer | Morningstar
China's Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
Innovent Biologics, Pfizer strike $10.5b partnership deal amid China biotech boom
Innovent shares rise 10% after pact with Pfizer of up to $10.5 billion
Pfizer inks up to $10.5 billion deal with China's Innovent Biologics
Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results
Pfizer, Innovent Sign Licensing Deal to Develop 12 Cancer Drugs | Morningstar
Should Pfizer's (PFE) New 25‑Valent Vaccine Data and Oncology Alliance Require Action From Investors?
Pfizer enters into global strategic collaboration with Innovent Biologics
Wall Street Rallies Amid U.S.-Iran Peace Deal Speculation
Valneva to Participate at U.S. and European Investor Conferences in June
Insiders Aren't Buying Pfizer Stock at $26 and That's Actually a Good Thing - 24/7 Wall St.
Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight
Geode Capital Management LLC Increases Stock Holdings in Pfizer Inc. $PFE - Daily Political
Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial
BNT162b2 LP.8.1 early vaccine effectiveness against COVID-19 emergency department, urgent care, and outpatient visits
Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders
Viking Therapeutics Buyout Buzz Meets VK2735 Obesity Drug Valuation Gap
Pfizer (NYSE:PFE) Shares Up 1.5% - Should You Buy? - Stock Observer
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference | Morningstar
Wealth Advisors of Tampa Bay LLC Lowers Holdings in Pfizer Inc. $PFE - Zolmax
Pfizer Inc. $PFE Shares Sold by Optimist Retirement Group LLC
BofA Raises Price Target on Pfizer (PFE) Following Strong Q1 Results
M3 Wealth Management LLC Purchases Shares of 23,777 Pfizer Inc. $PFE
Proactive prevention vital to ease pediatric respiratory disease burden: experts
Wealth Advisors of Tampa Bay LLC Sells 49,306 Shares of Pfizer Inc. $PFE - Daily Political
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy
3 Dividend Stocks Yielding Above 5% to Scoop Up Now
Astellas Targets ¥4.3 Trillion Profit Push As Xtandi Pressure Bu
Pfizer's BRAFTOVI® Becomes First Pfizer Therapy to Receive Priority Access Under Ontario's FAST Program, Accelerating Treatment for Canadians with Metastatic Colorectal Cancer
Is Pfizer Inc. (PFE) One of the Best Medical Stocks to Invest in According to Billionaires?
Pfizer (PFE) Valuation Check After New HYMPAVZI Approval Vaccine Data And Oncology Collaboration
Spotting Winners: Pfizer (NYSE:PFE) And Branded Pharmaceuticals Stocks In Q1
PFE: Obesity And Oncology Pipeline Progress Will Drive Long-Term Upside Potential
8 Best Retirement Stocks to Buy Now
Pfizer's CEO uses AI to make his biggest calls - and 64% of CEOs agree, quietly shifting your portfolio
Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38%
Review: "The New September 11th". Questions Persist Over Trust, Corruption, Big Pharma & COVID-19 Pandemic | Countercurrents
Morningstar Investment Management LLC Sells 68,676 Shares of Pfizer Inc. $PFE - Stock Observer
Sectoral Asset Management Inc. Lowers Stock Position in Pfizer Inc. $PFE - Stock Observer
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial
Swedbank AB Raises Holdings in Pfizer Inc. $PFE
St. Louis Trust Co Takes Position in Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Acquired by Swedbank AB - Stock Observer
St. Louis Trust Co Makes New $1.33 Million Investment in Pfizer Inc. $PFE - Stock Observer
Pfizer Oncology Partnerships Add Detail To Valuation And Earnings Concerns
SPHD Pays Monthly Income Without Fail Since 2012; Here's What Could Break the Streak - 24/7 Wall St.
Pfizer Inc. $PFE Shares Bought by Axxcess Wealth Management LLC
Americana Partners LLC Sells 144,747 Shares of Pfizer Inc. $PFE
LSV Asset Management Purchases 579,377 Shares of Pfizer Inc. $PFE - Daily Political
Here's Why Pfizer (PFE) Is One of the Most Undervalued US Stocks
Pzena Investment Management LLC Cuts Stake in Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Sold by Diamond Hill Capital Management Inc.
Pfizer Inc. $PFE Shares Bought by Global Retirement Partners LLC
Pfizer wins Singapore trademark dispute with Merck over vaccine brand
Heritage Investors Management Corp Trims Stake in Pfizer Inc. $PFE - Daily Political
Rathbones Group PLC Reduces Stock Position in Pfizer Inc. $PFE - Stock Observer
TREM2 agonists detailed in Pfizer patent | BioWorld
Favorable Auction Dynamics
Glucagon-Like Peptide (GLP)-1 Agonists Weight Loss Drugs Market Report 2026 Featuring Major Players Novo Nordisk A/S, Eli Lilly and Company, and Pfizer - Global Forecast to 2030 and 2035
Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals
Hemorrhoids Treatment Market Research Report 2026-2036: Epidemiological Analysis, Treatment and Management, Trends, Clinical Trial Landscape, Pipeline Analysis, Regulatory Landscape
Is Vaccine And Hematology Progress Reshaping The Investment Case For Pfizer (PFE)?
Pfizer Inc. $PFE Stake Lessened by Callahan Advisors LLC
How VEPPANU Approval Frames Expectations For AstraZeneca's Camizestrant In ESR1 Disease
Pfizer Advances Pneumonia Vaccine After 15-Fold Antibody Response Data
Three Dividend-Paying Healthcare Giants: Pfizer (PFE), AbbVie (ABBV), and Medtronic (MDT) Compared for 2026
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Phase 2 Data
Best Pharmaceutical Stocks To Research - May 20th - Daily Political
Pfizer (PFE) Advances Pneumococcal Vaccine Research with Promising Phase 2 Data
Pfizer Inc. $PFE Shares Acquired by Marble Harbor Investment Counsel LLC
Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results | Morningstar
Pfizer Advances Pneumonia Shot After Positive Study in Children
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results
Pfizer (NYSE:PFE) Trading Up 1.3% - Should You Buy?
The SoFi CEO Just Bought 70,000 Shares With His Own Money. Here Are Four More Under $30 Worth a Closer Look
Citi Initiates BridgeBio at Neutral: Why the Cardiomyopathy Story Isn't a Slam Dunk
Rate Cuts Are Off the Table. Here Are 2 Stocks Under $30 Built Exactly for This Moment
Pharmaceutical Stocks To Follow Now - May 19th - Daily Political
Payden & Rygel Increases Stock Position in Pfizer Inc. $PFE - Daily Political
Optimising patient centred drug development to realise impact
Pfizer's Low Valuation Tests Whether Seagen Growth Can Offset the Patent Cliff | Investing.com AU
Pfizer Inc. $PFE Shares Bought by Integrated Investment Consultants LLC - Zolmax
214,779 Shares in Pfizer Inc. $PFE Purchased by North Dakota State Investment Board
Pfizer Inc. (NYSE:PFE) Given Consensus Recommendation of "Hold" by Brokerages
FY2026 EPS Estimates for Pfizer Lowered by Erste Group Bank
Pfizer Inc. $PFE Holdings Lifted by Integrated Investment Consultants LLC - Daily Political
Top Pharmaceutical Stocks To Keep An Eye On - May 17th - Stock Observer
John G Ullman & Associates Inc. Increases Stock Holdings in Pfizer Inc. $PFE
Pfizer Inc. $PFE Stock Holdings Boosted by Canada Post Corp Registered Pension Plan
Pfizer Inc. $PFE Position Trimmed by Stephens Inc. AR - Daily Political
The Top 5 Analyst Questions From Novavax's Q1 Earnings Call
Novo Nordisk Refocuses Odense Spend Toward GLP-1 Growth Priorities
Wolfe Research Says COVID Uncertainty Continues to Weigh on Pfizer (PFE) Outlook
DNB Asset Management AS Acquires 486,895 Shares of Pfizer Inc. $PFE - Stock Observer
Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Oncology Growth Expectations
PFIZER News
Markets.com vs eToro: Key Differences Every South Africa CFD Trader Should Know
Markets.com Review 2026: Complete Account Opening Guide, Deposit, Withdrawal & Demo Test
S&P 500 Analysis: S&P 500 Trading Landscape Changes as Wall Street Reacts to Economic Data
Latest news
Show more
Islamic Green Finance: Dubai Islamic Bank Launches $500mn Green Sukuk to Fund Sustainable Projects
Gold Price Today, May 29: XAUUSD Holds Steady Above $4,500 Amid Market Volatility
JSE Resilience Amid Volatility: Key Stock Moves and Market Outlook for May 2026
Gold Price Today, May 28: Gold Tests Key Support Near $4,440 Amid Fed and Yield Pressures
Oil Price Today: Middle East Tensions Push Oil Above $100, European Energy Stocks Surge on Higher Crude
UAE’s Explosive AI Growth: UAE Tops Global AI Adoption for Third Straight Quarter at 70.1% Usage Rate
